Armata Pharmaceuticals, Inc.

ARMP · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$19-$69-$37-$23
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$1$0$3
Change in WC-$2-$10$0-$3
Other Non-Cash-$21$29$3-$1
Operating Cash Flow-$38-$47-$32-$24
Investing Activities
PP&E Inv.-$2-$8-$2-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2-$8-$2-$1
Financing Activities
Debt Repay.$35$54$0$0
Stock Issued$0$0$45$26
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$1-$1
Financing Cash Flow$35$54$44$26
Forex Effect$0$0-$5$0
Net Chg. in Cash-$4-$2$5$1
Supplemental Information
Beg. Cash$19$21$10$11
End Cash$15$19$15$11
Free Cash Flow-$39-$56-$35-$25
Armata Pharmaceuticals, Inc. (ARMP) Financial Statements & Key Stats | AlphaPilot